November 20, 2026

To avoid fractures, elderly prefer pill to device

In a survey of 67 adults, who were mean of 78 years old, at risk for hip fracture due to the bone-thinning disease osteoporosis, the majority stated a preference for taking a bone-building pill over wearing an external hip protector.

bdnews24.com News Service

bdnews24.com

Published : 23 Nov 2006, 06:00 PM

Updated : 17 Aug 2022, 06:54 PM

NEW YORK, Nov 24 (bdnews24.com/Reuters) - In a survey of 67 adults, who were mean of 78 years old, at risk for hip fracture due to the bone-thinning disease osteoporosis, the majority stated a preference for taking a bone-building pill over wearing an external hip protector. However, as the survey's authors point out, a limitation of the survey was that more than half of those surveyed (57 percent) were currently taking a so-called bisphosphonate (like Boniva) and none had ever heard of a hip protector. "We could not recruit sufficient numbers of treatment-naïve, high-risk participants at a relevant point in decision-making," Dr Liana Fraenkel and colleagues from Yale University School of Medicine in New Haven, Connecticut, admit. Therefore, the extent to which the findings can be generalised is limited. Preference for hip protectors was stronger among participants not currently using a bisphosphonate (36 percent vs 19 percent) and among those favouring non-drug ways to address health problems (44 percent vs 12 percent). In general, "participants were more strongly influenced by the type of treatment than expected benefits, and when given a choice most preferred taking a pill over wearing a hip protector," the authors note. For example, when told that both options were equally effective, 9 percent preferred hip protectors, 88 percent weekly oral bisphosphonates, and 3 percent refused all options. When told hip protectors were more effective than bisphosphonates, 26 percent still preferred hip protectors, 71 percent bisphosphonates, and 3 percent continued to refuse both. The current survey suggests that hip protectors, as currently manufactured, are unlikely to be a widely accepted treatment option among community-dwelling older adults," Fraenkel and colleagues conclude. Future trials and education programmes, they add, should consider targeting respondents who prefer to manage health problems without drugs since, "based on the results of this study, adherence and proper use of hip protectors would be expected to be higher among these patients." bdnews24.com/srs/1015 hrs
Related Stories